Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055149989> ?p ?o ?g. }
- W2055149989 endingPage "99" @default.
- W2055149989 startingPage "91" @default.
- W2055149989 abstract "The aim of this study was to determine in vitro protein binding of tolterodine and its 5-hydroxymethyl (5-HM) and N-dealkylated metabolites in serum from humans and several animal species at concentrations similar to those obtained in clinical and preclinical studies. Binding of tolterodine and the two metabolites to human serum albumin and α1-acid glycoprotein (AAG) was also assessed, as was binding of tolterodine to red blood cells. Ex vivo protein binding of tolterodine and 5-HM was determined in serum samples from healthy volunteers treated with oral tolterodine 4 mg twice daily for 8 days. Tolterodine exhibited high protein binding in human serum; the unbound fraction (fu) was 3.7%. The unbound fraction of tolterodine in cat and dog serum (1.5 and 2.1%, respectively) was lower compared with human serum; fu was higher in the other species investigated (rat, 22%; mouse, 16–17%; rabbit, 39%). The unbound fraction of 5-HM was much higher in serum from humans (36%) and all animal species investigated (mouse, 72%; rabbit, 68%; cat, 32%; dog, 45%). Binding of N-dealkylated tolterodine to proteins in human serum was intermediate (fu 14%). AAG was the major binding protein for tolterodine and 5-HM, and the degree of binding increased with increasing concentration of the protein. The association constant of 5-HM for AAG was lower than that of tolterodine (1.3×105 M−1 versus 2.1×106 M−1). The blood:plasma tolterodine concentration ratio was 0.6 in both humans and dog; thus, a minor fraction of tolterodine was present in red blood cells compared with plasma (0.18 and 0.36, respectively). In the mouse, tolterodine was equally present in blood and plasma. In ex vivo samples, fu values for tolterodine (pH adjusted) varied between 1.6 and 4.9% (mean 2.8%), which could be explained by differences in AAG concentrations. There was good correlation between observed fu values for tolterodine and those predicted on the basis of AAG levels. Similar findings were observed for 5-HM. Copyright © 1999 John Wiley & Sons, Ltd." @default.
- W2055149989 created "2016-06-24" @default.
- W2055149989 creator A5011184543 @default.
- W2055149989 creator A5083194006 @default.
- W2055149989 date "1999-03-01" @default.
- W2055149989 modified "2023-10-01" @default.
- W2055149989 title "Serum protein binding of tolterodine and its major metabolites in humans and several animal species" @default.
- W2055149989 cites W1963743345 @default.
- W2055149989 cites W1965250537 @default.
- W2055149989 cites W1967031158 @default.
- W2055149989 cites W1977586210 @default.
- W2055149989 cites W1985801662 @default.
- W2055149989 cites W2005791359 @default.
- W2055149989 cites W2015838352 @default.
- W2055149989 cites W2019727704 @default.
- W2055149989 cites W2044988410 @default.
- W2055149989 cites W2048680522 @default.
- W2055149989 cites W2064430566 @default.
- W2055149989 cites W2065423157 @default.
- W2055149989 cites W2073149905 @default.
- W2055149989 cites W2075440166 @default.
- W2055149989 cites W2079675222 @default.
- W2055149989 cites W2082235615 @default.
- W2055149989 cites W2162632962 @default.
- W2055149989 cites W2164810824 @default.
- W2055149989 cites W2336516640 @default.
- W2055149989 cites W2339179533 @default.
- W2055149989 cites W342535448 @default.
- W2055149989 doi "https://doi.org/10.1002/(sici)1099-081x(199903)20:2<91::aid-bdd162>3.0.co;2-y" @default.
- W2055149989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10206324" @default.
- W2055149989 hasPublicationYear "1999" @default.
- W2055149989 type Work @default.
- W2055149989 sameAs 2055149989 @default.
- W2055149989 citedByCount "51" @default.
- W2055149989 countsByYear W20551499892012 @default.
- W2055149989 countsByYear W20551499892013 @default.
- W2055149989 countsByYear W20551499892014 @default.
- W2055149989 countsByYear W20551499892016 @default.
- W2055149989 countsByYear W20551499892017 @default.
- W2055149989 countsByYear W20551499892018 @default.
- W2055149989 countsByYear W20551499892021 @default.
- W2055149989 countsByYear W20551499892023 @default.
- W2055149989 crossrefType "journal-article" @default.
- W2055149989 hasAuthorship W2055149989A5011184543 @default.
- W2055149989 hasAuthorship W2055149989A5083194006 @default.
- W2055149989 hasConcept C112705442 @default.
- W2055149989 hasConcept C126322002 @default.
- W2055149989 hasConcept C134018914 @default.
- W2055149989 hasConcept C142724271 @default.
- W2055149989 hasConcept C146543888 @default.
- W2055149989 hasConcept C150903083 @default.
- W2055149989 hasConcept C185592680 @default.
- W2055149989 hasConcept C204787440 @default.
- W2055149989 hasConcept C207001950 @default.
- W2055149989 hasConcept C2776125364 @default.
- W2055149989 hasConcept C2778597219 @default.
- W2055149989 hasConcept C2778941218 @default.
- W2055149989 hasConcept C2781020410 @default.
- W2055149989 hasConcept C2781233306 @default.
- W2055149989 hasConcept C51639874 @default.
- W2055149989 hasConcept C55493867 @default.
- W2055149989 hasConcept C71924100 @default.
- W2055149989 hasConcept C86803240 @default.
- W2055149989 hasConcept C98274493 @default.
- W2055149989 hasConceptScore W2055149989C112705442 @default.
- W2055149989 hasConceptScore W2055149989C126322002 @default.
- W2055149989 hasConceptScore W2055149989C134018914 @default.
- W2055149989 hasConceptScore W2055149989C142724271 @default.
- W2055149989 hasConceptScore W2055149989C146543888 @default.
- W2055149989 hasConceptScore W2055149989C150903083 @default.
- W2055149989 hasConceptScore W2055149989C185592680 @default.
- W2055149989 hasConceptScore W2055149989C204787440 @default.
- W2055149989 hasConceptScore W2055149989C207001950 @default.
- W2055149989 hasConceptScore W2055149989C2776125364 @default.
- W2055149989 hasConceptScore W2055149989C2778597219 @default.
- W2055149989 hasConceptScore W2055149989C2778941218 @default.
- W2055149989 hasConceptScore W2055149989C2781020410 @default.
- W2055149989 hasConceptScore W2055149989C2781233306 @default.
- W2055149989 hasConceptScore W2055149989C51639874 @default.
- W2055149989 hasConceptScore W2055149989C55493867 @default.
- W2055149989 hasConceptScore W2055149989C71924100 @default.
- W2055149989 hasConceptScore W2055149989C86803240 @default.
- W2055149989 hasConceptScore W2055149989C98274493 @default.
- W2055149989 hasIssue "2" @default.
- W2055149989 hasLocation W20551499891 @default.
- W2055149989 hasLocation W20551499892 @default.
- W2055149989 hasOpenAccess W2055149989 @default.
- W2055149989 hasPrimaryLocation W20551499891 @default.
- W2055149989 hasRelatedWork W1988461831 @default.
- W2055149989 hasRelatedWork W2055149989 @default.
- W2055149989 hasRelatedWork W2068543243 @default.
- W2055149989 hasRelatedWork W2073638061 @default.
- W2055149989 hasRelatedWork W2074491172 @default.
- W2055149989 hasRelatedWork W2127867331 @default.
- W2055149989 hasRelatedWork W2136788618 @default.
- W2055149989 hasRelatedWork W2162632962 @default.
- W2055149989 hasRelatedWork W2426588295 @default.
- W2055149989 hasRelatedWork W3122390182 @default.